Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $45.76 million. The enterprise value is -$37.97 million.
| Market Cap | 45.76M |
| Enterprise Value | -37.97M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 38.13 million shares outstanding. The number of shares has increased by 1.21% in one year.
| Shares Outstanding | 38.13M |
| Shares Change (YoY) | +1.21% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 3.94% |
| Owned by Institutions (%) | 59.55% |
| Float | 21.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.81 |
| Forward PS | 5.00 |
| PB Ratio | 0.41 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.18.
| Current Ratio | 5.17 |
| Quick Ratio | n/a |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -51.20% and return on invested capital (ROIC) is -57.31%.
| Return on Equity (ROE) | -51.20% |
| Return on Assets (ROA) | -37.80% |
| Return on Capital (ROIC) | -57.31% |
| Revenue Per Employee | $78,760 |
| Profits Per Employee | -$691,970 |
| Employee Count | 100 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.82% in the last 52 weeks. The beta is 0.99, so BOLT's price volatility has been similar to the market average.
| Beta (1Y) | 0.99 |
| 52-Week Price Change | -26.82% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 49.82 |
| Average Volume (30 Days) | 130,266 |
Short Selling Information
The latest short interest is 1.97 million, so 5.17% of the outstanding shares have been sold short.
| Short Interest | 1.97M |
| Short Previous Month | 1.96M |
| Short % of Shares Out | 5.17% |
| Short % of Float | 9.31% |
| Short Ratio (days to cover) | 11.95 |
Income Statement
In the last 12 months, BOLT had revenue of $7.88 million and -$69.20 million in losses. Loss per share was -$1.83.
| Revenue | 7.88M |
| Gross Profit | 7.88M |
| Operating Income | -76.20M |
| Pretax Income | -69.20M |
| Net Income | -69.20M |
| EBITDA | -64.39M |
| EBIT | -69.20M |
| Loss Per Share | -$1.83 |
Balance Sheet
The company has $103.95 million in cash and $20.22 million in debt, giving a net cash position of $83.74 million or $2.20 per share.
| Cash & Cash Equivalents | 103.95M |
| Total Debt | 20.22M |
| Net Cash | 83.74M |
| Net Cash Per Share | $2.20 |
| Equity / Book Value | 112.74M |
| Book Value Per Share | 2.96 |
| Working Capital | 85.25M |
Cash Flow
In the last 12 months, operating cash flow was -$69.53 million and capital expenditures -$206,000, giving a free cash flow of -$69.73 million.
| Operating Cash Flow | -69.53M |
| Capital Expenditures | -206,000 |
| Free Cash Flow | -69.73M |
| FCF Per Share | -$1.84 |
Margins
Gross margin is 100.00%, with operating and profit margins of -967.45% and -878.58%.
| Gross Margin | 100.00% |
| Operating Margin | -967.45% |
| Pretax Margin | -878.58% |
| Profit Margin | -878.58% |
| EBITDA Margin | -817.56% |
| EBIT Margin | -878.58% |
| FCF Margin | -885.36% |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.21% |
| Shareholder Yield | -1.21% |
| Earnings Yield | -151.21% |
| FCF Yield | -152.38% |
Analyst Forecast
The average price target for BOLT is $6.00, which is 399.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 399.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 47.46% |
| EPS Growth Forecast (5Y) | -8.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BOLT has an Altman Z-Score of -3.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.35 |
| Piotroski F-Score | 2 |